Product Images Alfuzosin Hydrochloride

The text describes a graph or chart showing the mean change between a placebo (N=167) and Altuzosin hydrochloride extended-release tablets (N=170) at different treatment durations (28, 56, and 84 days). The graph also indicates a statistically significant difference (p<0.001) between the two treatments.*

This text appears to be a data table showing the mean change in some variable after a certain number of days of treatment with a placebo or Alfuzosin hydrochloride extended-release tablets. The number of participants in each group is also provided. The significance level of p < 0.01 is noted. However, the variable being measured and the units are not specified, so it is not possible to provide a more specific description.*

This appears to be a graph presenting the mean change in something over 28 and 56 days of treatment with a placebo compared to Altuzosin hydrochloride extended-release tablets, where the latter achieved a statistically significant improvement (p < 0.01) over the former. The specific thing being measured is not provided, so further information is not available.*

The text shows a graph displaying the mean change in mL/s for a placebo group and a group treated with alfuzosin hydrochloride extended-release tablets over 56-84 days. The graph indicates a statistically significant difference between the two groups.*

This appears to be a graph representing the mean change in mL/s over time for a placebo group and a group taking Alfuzosin hydrochloride extended-release tablets. The x-axis appears to represent days of treatment, while the y-axis represents mean change in mL/s. The graph shows that the group taking the medication saw a greater mean change in mL/s over time compared to the placebo group. The asterisk next to "p<0.05" suggests that this difference is statistically significant.*

This text provides information about a medication called "Extendodoieaso tablet" that contains "Oscemsarans e eB[fUZ0STN Hydrochloride". The drug comes in a container that is light-resistant and meets the USP standards. It is recommended to store the drug at 20-25°C. The drug is extended-release tablets and should be kept out of reach of children. The manufacturer of the drug is Unichem Laboratories Ltd. The text also provides information about the location of manufacturing of this drug.*